When it Comes to CBD, the FDA Wants to See the Receipts

June 6, 2019

When it comes to cannabidiol (CBD), the U.S. Food and Drug Administ­ration (FDA) isn’t quite ready to take a hit.
On Friday, May 31, 2019, the agency held its first hearing on CBD in Silver Spring, Maryland. More than 100 people testified, reports CNBC, many of whom extolled the virtues of CBD and its benefits—and implored the agency to set up a regulatory framework to legally add CBD to food products and dietary supplements.
Read more at Skin Inc. >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Raging Agency Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Medical Marketing Whiz Announces Partnership With Boulevard to Help Med Spas and Wellness Clinics Streamline Operations
    • ByrdAdatto Attorneys Recognized in the 2027 Edition of Best Lawyers
    • RHA Redensity Eye Receives FDA Approval for Undereye Hollowing
    • South Carolina Medical Board Warns Against Use of Research-Grade Peptides